Journal of Enzyme Inhibition and Medicinal Chemistry publishes open access research on enzyme inhibitors, inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents.
Journal of Enzyme Inhibition and Medicinal Chemistry aims to provide an international and interdisciplinary platform for the latest findings in enzyme inhibition research.
The journal’s focus includes current developments in:
Enzymology
Cell biology
Chemical biology
Microbiology
Physiology
Pharmacology leading to drug design
Molecular recognition processes
Distribution and metabolism of biologically active compounds
Across these fields of study, special attention is given to:
Journal of Enzyme Inhibition and Medicinal Chemistry accepts original articles, reviews/systematic reviews, methods, brief reports, data notes, discussions, editorials and letters to the editor.
The journal operates a single anonymized peer review policy.
42 days avg. from submission to first
post-review decision
21 days avg. from acceptance to online
publication
38% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmaceutical Chemistry, University of Florence, Florence, Italy
Associate Editors
Clemente Capasso - Consiglio Nazionale della Ricerche, Naples, Italy Alex Donald - University of New South Wales, Sydney, Australia Binghe Wang - Georgia State University, Georgia, Atlanta, USA Jean-Yves Winum - University of Montpellier, Montpellier,France
Editorial Board
Zeid Alothman - King Saud University, Riyadh, Saudi Arabia Atanas G. Atanasov - Medical University of Vienna, Vienna, Austria Mohammed Arifuddi n - National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India Simone Carradori - Chieti University, Chieti, Italy Fabrizio Carta - University of Florence, Florence, Italy Pedro Colinas - Universidad Nacional de La Plata, Buenos Aires, Argentina Deniz Ekinci - Ondokuz Mayis University, Samsun, Turkey Wagdy H. Eldehna - Kafrelsheikh University, Kafr El Sheikh, Egypt Daniel P. Flaherty - Purdue University, West Lafayette, Indiana, USA Ozlen Guzel - Istanbul University, Istanbul,Turkey Dimitra Hadjipavlou-Litina - Aristotle University, Thessaloniki, Greece Marc A Ilies - Temple University, Philadelphia, USA Bogdan Iorga – National Centre of Scientific Research (CNRS), Gif sur Yvette, France Jan Korábečný - University Hospital Hradec Kralove and University of Defence, Hradec Kralove, Czech Republic Marc Le Borgn e - University Claude Bernard Lyon 1, Lyon, France Óscar López - University of Seville, Seville, Spain Robert McKenna - University of Florida, Gainesville, Florida, USA Mattia Mori - University of Siena, Siena, Italy Dario Neri - ETH Zurich, Zurich, Switzerland Seppo Parkkila - University of Tampere, Tampere, Finland Silvia Pastorekova - Slovak Academy of Sciences, Bratislava, Slovakia Mariana Pinteala - Petru Poni Institute, Iaşi, Romania Des Richardson - Griffith Institute for Drug Discovery, Brisbane, Australia Mario Sechi - University of Sassari, Sassari, Italy Claire Simons - Cardiff University, Cardiff, UK Sibel Süzen - Ankara University, Ankara, Turkey Sebastien Thibaudeau - University of Poitiers, Poitiers, France Dimitrios Tsikas - University of Hannover, Hannover, Germany Tiziano Tuccinardi - Pisa University, Pisa, Italy Alane B Vermelho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil Raivis Zalubovskis - Institute of Organic Synthesis, Rīga, Latvia Peng Zhan - School of Pharmaceutical Sciences, Shandong University, Jinan, China
Updated: 04-06-2024
Abstracting and indexing
Journal of Enzyme Inhibition and Medicinal Chemistry is included in the following abstracting and indexing services:
Current Contents: Life Sciences; Science Citation Index; Research Alert; SciSearch; BIOSIS; Biotechnology Citation Index; Elsevier BIOBASE/Current Awareness in Biological Sciences; Chemical Abstracts; DOAJ; EMBASE/Excerpta Medica; Current Science Ltd; Index Medicus/Medline; SCOPUS; SIIC; Sheffield University Biomedical Information Services (SUBIS).
Open access
Journal of Enzyme Inhibition and Medicinal Chemistry is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Journal of Enzyme Inhibition and Medicinal Chemistry
(2002 - current)
Formerly known as
Journal of Enzyme Inhibition
(1985 - 2001)
Advertising information
Would you like to advertise in Journal of Enzyme Inhibition and Medicinal Chemistry?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Journal of Enzyme Inhibition and Medicinal Chemistry.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
![HRB Open Research is a platform for HRB-funded researchers to rapidly publish their research outputs in an open and accessible way.]({"type":"image" , "src" : "/sda/112432/HRB-KB.jpg"})